# | ||||
---|---|---|---|---|
1 | WIBEC Wireless In-Body Environment | 2016 | 3˙957˙045.00 | 3˙957˙045.00 |
2 | LUMIBLAST A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours | 2016 | 3˙031˙375.00 | 3˙031˙375.00 |
3 | HIPERNAV High Performance Soft-tissue Navigation | 2016 | 4˙041˙920.00 | 4˙041˙920.00 |
4 | IMPRESS Imaging Perfusion Restrictions from Extracellular Solid Stress | 2018 | 1˙499˙638.00 | 1˙499˙638.00 |
5 | FRINGE Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies | 2019 | 3˙979˙485.00 | 3˙979˙485.00 |
6 | GLIOHAB Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation | 2019 | 214˙158.00 | 214˙158.00 |
The Institution OSLO UNIVERSITETSSYKEHUS HF has been involved also in the following Horizon 2020 projects.